Daxor (NASDAQ:DXR) Shares Up 0.8% – Here’s What Happened

Daxor Co. (NASDAQ:DXR) shares rose 0.8% during trading on Wednesday . The company traded as high as $7.75 and last traded at $7.69. Approximately 24,226 shares changed hands during trading, an increase of 221% from the average daily volume of 7,537 shares. The stock had previously closed at $7.63.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets upped their price objective on shares of Daxor from $24.50 to $24.75 and gave the stock a “buy” rating in a report on Monday, September 9th.

Daxor Trading Up 2.9 %

The stock’s 50 day moving average is $8.76 and its 200 day moving average is $8.88.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Daxor stock. Keyes Stange & Wooten Wealth Management LLC raised its stake in Daxor Co. (NASDAQ:DXR) by 34.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,612 shares of the company’s stock after buying an additional 3,771 shares during the period. Keyes Stange & Wooten Wealth Management LLC owned approximately 0.30% of Daxor worth $126,000 as of its most recent filing with the SEC. 1.34% of the stock is owned by institutional investors and hedge funds.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.